27 January 2021 - NICE has completed its review of trifluridine with tipiracil hydrochloride for the treatment of patients with ...
27 January 2021 - Global Blood Therapeutics today announced that the EMA has completed the validation of GBT’s marketing authorisation application ...
26 January 2021 - Keytruda is first checkpoint inhibitor approved in Europe to treat MSI-H or dMMR colorectal cancer. ...
27 January 2021 - Bristol Myers Squibb’s Revlimid (lenalidomide) has received a recommendation from the UK’s NICE for newly diagnosed ...
26 January 2021 - NICE has had another look at abiraterone acetate for the treatment of patients with newly diagnosed ...
26 January 2021 - Carbaglu is first and only FDA approved medication for hyperammonaemia associated with these rare conditions. ...
26 January 2021 - FDA grants priority review of the application and sets a PDUFA target action date of 8 June ...
26 January 2021 - Symbicort Turbuhaler becomes the first dual-combination therapy approved in China for mild, moderate and severe asthma ...
25 January 2021 - FDA has granted odevixibat fast track, rare paediatric disease and orphan drug designations. ...
25 January 2021 - If approved, first oral penem in the U.S. and first new oral treatment for uUTIs in over ...
25 January 2021 - Approval is supported by data from three pivotal clinical studies in psoriatic arthritis and ankylosing spondylitis where ...
25 January 2021 - The EMA has published a draft agenda for this week's CHMP meeting. ...
25 January 2021 - 88% of patients on Calquence remained free of disease progression after 12 months vs. 68% for ...
25 January 2021 - BAVENCIO maintenance treatment significantly extended median overall survival versus standard of care in the Phase 3 JAVELIN ...
25 January 2021 - Junshi Biosciences announced today that U.S. FDA has granted toripalimab fast track designation for the first-line treatment ...